The response to pegylated interferon (pegIFN) plus ribavirin (RBV) as treatment of chronic
hepatitis C virus (HCV) infection is lower in HIV-coinfected than in HCV-monoinfected patients …

There is limited information on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
T‐cell immune responses in patients with coronavirus disease 2019 (COVID‐19). Both …

Background A low CD4/CD8 ratio during antiretroviral therapy (ART) identifies people with
heightened immunosenescence and increased risk of mortality. We aimed to assess the …

Background. Sustained virological response (SVR) after therapy with interferon plus
ribavirin reduces liver-related complications and mortality in patients coinfected with human …

The NNRTI efavirenz has long been one of the most frequently employed antiretroviral
drugs in the multidrug regimens used to treat HIV infection, in accordance with its well-…

There is scarce information on the frequency of co-detection of respiratory pathogens (RP) in
patients with Covid-19. Documentation of coinfections in Covid-19 pneumonia patients may …

Background. To report the clinical and epidemiological characteristics of hepatocellular
carcinoma (HCC) diagnosed in a cohort of human immunodeficiency virus (HIV)–infected …

This study assessed the prevalence and patterns of drug use among people living with HIV (PLHIV)
in Spain. We conducted an observational cross-sectional study including 1401 …

We assessed non‐liver‐related non–acquired immunodeficiency syndrome (AIDS)‐related (NLR‐NAR)
events and mortality in a cohort of human immunodeficiency virus (HIV)/hepatitis …

Background Late HIV diagnosis remains one of the challenges in combating the epidemic.
Primary care providers play an important role in screening for HIV infection. Our study aims to …